Commodore Capital
New York, USA · Series A → Growth
Their stated focus (public profile)
Commodore Capital invests in innovative biopharmaceutical companies to improve patients' lives. The firm believes the industry is in an early stage of a major innovation cycle, with scientific discoveries translating into clinical breakthroughs through novel therapeutic modalities such as genetic medicines and cellular therapies. Much of this innovation is occurring within smaller biopharmaceutical companies, and Commodore aims to be a strong partner to these companies as they develop new medicines.
Stages: Series A → Growth
Sectors: Life sciences
Website: commodorecapital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.